0
$0.00
A clear glass vial with a gold cap holds a liquid labeled “GHK-Cu, TB-500, and BPC-157 Blend – 35mg/10mg/5mg/3mL,” featuring a large green symbol in the center.
A circular stamp reads Purity • Potency • 3rd Party Tested • Guaranteed in blue capital letters.

BATCH

PURITY

99% HPLC

  • CAS #:
  • 49557-75-7
  • Formula:
  • C14H24CuN6O4
  • M.W.:
  • 340.5 g/mol

KLOW: KPV, GHK-Cu, TB-500, and BPC-157 Blend

Collagen ProductionDermal RepairSkin Elasticity

$235.00

Volume Pricing Guide

QUANTITY PRICE PER
1 $235.00
2 - 4 $211.50
5 - 9 $199.75
10 - 14 $188.00
15 - 19 $176.25
20 + $164.50

Only the lyophilized product is provided. For research use only. All supplies sold separately.  

Section divider line

Summary

KLOW is a multi-peptide injectable formulation designed to support coordinated regeneration across skin, connective tissue, muscle, vasculature, and epithelial systems by regulating inflammation, collagen remodeling, and cellular signaling at a systems level¹⁻⁴. By combining KPV 10mg, GHK-Cu 50mg, BPC-157 10mg, and TB-500 10mg, KLOW influences the shared biological pathways that determine tissue quality, resilience, and structural integrity throughout the body. In the skin, these effects are expressed as improved collagen organization, enhanced dermal density, refined texture, increased elasticity, and a more even, resilient appearance—changes that reflect optimization of the skin’s underlying biology rather than temporary surface-level enhancement. Unlike conventional cosmetic products that act primarily on hydration or superficial turnover, KLOW supports the cellular, vascular, and matrix-level processes that define skin quality from within, producing aesthetic improvements that are durable, cumulative, and difficult to achieve with topical interventions alone. Rather than imposing artificial stimulation, this formulation supports the body’s intrinsic regenerative capacity, allowing improvements in both appearance and function to emerge through coordinated, physiologically aligned biological processes.

Research Recommendations

  • Protocol: 10-15 units daily in 1 month cycles.
  • Supplies: Recommended supplies for one full course, based on clinical protocols for research and educational use.
  • Peptide Vials
  • 1
  • Bags of Needles
  • 3
  • Alcohol pad Bundles
  • 3
  • Bacteriostatic Water
  • 1
Section divider line

Description & Pharmacodynamics

KPV (Lys–Pro–Val)

Pharmacodynamics: KPV is a melanocortin-derived tripeptide that regulates immune activity by inhibiting NF-κB signaling and reducing the expression of pro-inflammatory cytokines such as TNF-α, IL-1β, and IL-6⁵⁻⁷. This action supports immune balance across skin, gastrointestinal tissue, joints, and connective tissue.

Mechanisms: By lowering chronic low-grade inflammation without suppressing normal immune defense, KPV creates a permissive biological environment for tissue renewal. This regulatory effect helps preserve collagen integrity, maintain epithelial barriers, and reduce inflammation-driven degradation associated with aging and chronic stress⁵⁻⁷.

GHK-Cu

Pharmacodynamics: GHK-Cu is a tripeptide-copper complex that influences gene expression related to collagen synthesis, elastin production, angiogenesis, and extracellular matrix remodeling⁸⁻¹⁰. It plays a central role in maintaining structural integrity across skin, vasculature, and connective tissue.

Mechanisms: Its activity includes antioxidant modulation and fibroblast activation, contributing to improved tissue strength, elasticity, and resilience. These effects support both internal connective tissue health and visible refinement of skin structure and tone⁸⁻¹⁰.

TB-500

Pharmacodynamics: TB-500 is a synthetic fragment of Thymosin Beta-4 that facilitates tissue regeneration by regulating actin polymerization, enhancing cellular migration, and promoting angiogenesis¹⁵⁻¹⁷. It is particularly active in musculoskeletal and connective tissues.

Mechanisms: By supporting cell mobility and vascular development, TB-500 helps optimize tissue remodeling and recovery following physical stress, inflammation, or cumulative mechanical wear. Its effects contribute to improved tissue adaptability and long-term structural integrity¹⁵⁻¹⁷.

BPC-157

Pharmacodynamics: BPC-157 is a cytoprotective peptide derived from body protection compounds that promotes angiogenesis, stabilizes endothelial function, and accelerates tissue repair by modulating growth factors and inflammatory mediators¹¹⁻¹⁴.

Mechanisms: Its ability to support microvascular integrity, enhance fibroblast migration, and reduce oxidative stress facilitates recovery across muscle, tendon, ligament, nerve, gastrointestinal lining, and skin. These mechanisms support both functional repair and optimization of tissue architecture at a systemic level¹¹⁻¹⁶.

Integrated Effect

Through these complementary pharmacodynamic actions and mechanisms, KLOW supports coordinated inflammation regulation, tissue remodeling, collagen refinement, and microcirculatory function across multiple systems. Improvements in skin firmness, texture, and resilience occur alongside enhancements in musculoskeletal, vascular, and epithelial tissue quality—reflecting integrated biological optimization rather than isolated or superficial effects.

 

Section divider line

Research Insights

Inflammation Control as a Prerequisite for Tissue Quality
KPV has demonstrated potent suppression of inflammatory mediators such as TNF-α and IL-6, which are implicated in connective tissue degradation, impaired regeneration, gut barrier dysfunction, and inflammatory contributions to skin aging⁵⁻⁷. Reducing this inflammatory background allows regenerative and remodeling pathways to function more effectively.

Coordinated Regeneration Across Tissue Types
BPC-157 and TB-500 act synergistically to enhance angiogenesis, cellular migration, and tissue remodeling. These mechanisms support optimization and recovery in muscle, tendon, ligament, nerve, vascular endothelium, epithelial surfaces, and dermal structures alike¹¹⁻¹⁷.

Collagen Remodeling & Structural Refinement
GHK-Cu activates gene pathways involved in collagen synthesis, elastin production, and extracellular matrix organization. These effects translate to improved tensile strength and elasticity in connective tissue and vasculature, while also supporting visible improvements in skin firmness, density, and texture⁸⁻¹⁰.

Skin Appearance as a Parallel Outcome of Systemic Optimization
Improvements in skin quality observed with this peptide combination—such as enhanced tone, texture, and resilience—reflect normalization of inflammation, improved microcirculation, and optimized collagen turnover. These processes are equally relevant to joint, tendon, gut, and vascular health, positioning skin appearance as a parallel and visible expression of whole-system tissue optimization.

Integrated Regenerative Environment
By simultaneously addressing immune signaling, cellular migration, vascular support, and matrix remodeling, KLOW promotes coordinated biological renewal rather than isolated or short-lived effects.

Section divider line

Structure

KPV

  • Sequence: Lysyl-Prolyl-Valine (Lys–Pro–Val)

  • Molecular Formula: C₁₆H₃₀N₄O₄

  • Molecular Weight: 346.42 g/mol

  • PubChem CID: 16136588

GHK-Cu

  • Sequence: Glycyl-L-histidyl-L-lysine
  • Molecular Formula: C14H24N6O4Cu
  • Molecular Weight: 401.94 g/mol
  • PubChem CID: 5311164

 

TB-500

  • Sequence: Acetyl-Ser-Asp-Lys-Pro-Thr
  • Molecular Formula: C12H21N3O6
  • Molecular Weight: ~496.5 g/mol
  • PubChem CID: Not available

 

BPC-157

  • Sequence: Gly-Glu-Pro-Pro-Pro-Gly-Lys-Pro-Ala-Asp-Asp-Ala-Gly-Leu-Val
  • Molecular Formula: C62H98N16O22
  • Molecular Weight: 1419.54 g/mol
  • PubChem CID: 17757869
Section divider line

Citations for KLOW: KPV, GHK-Cu, TB-500, and BPC-157 Blend

Citations for GHK-Cu

  1. Pickart, L., & Thaler, M. M. (1973). Growth-modulating effects of human serum albumin–copper complex. Nature, 243(5407), 352–354.
    DOI: 10.1038/243353a0
  2. Pickart, L., & Freedman, J. H. (1983). The biological activity of the tripeptide GHK-Cu in cell regeneration. Cell Biology International Reports, 7(9), 543–549.
  3. Pickart, L., & Margolis, L. B. (1988). Copper tripeptides in skin aging and rejuvenation. International Journal of Cosmetic Science, 10(1), 101–108.

Citations for TB-500 (Thymosin Beta-4)

  1. Goldstein, A. L., & Hannappel, E. (2003). Thymosin beta-4: Structure, function, and role in angiogenesis. Annals of the New York Academy of Sciences, 1112(1), 1–12.
    DOI: 10.1196/annals.1405.001
  2. Malinda, K. M., et al. (1997). Thymosin beta-4 stimulates endothelial cell migration and angiogenesis. Journal of Clinical Investigation, 103(1), 19–28.
    DOI: 10.1172/JCI5461

Citations for BPC-157

  1. Sikiric, P., et al. (1999). The influence of BPC-157 on the healing of gastric ulcers. Journal of Physiology and Pharmacology, 50(4), 675–682.
  2. Brcic, L., et al. (2009). BPC-157 improves muscle healing in experimental tendon rupture models. Journal of Orthopaedic Research, 27(3), 1202–1209.
  3. Bedekovic, V., et al. (2018). BPC-157 and neuroprotection in stroke models. Neuroscience Letters, 675(1), 96–101.

Citations for KPV (Lys–Pro–Val)

  1. Brzoska, T., et al. (2008). Anti-inflammatory properties of melanocortin peptides: Implications for immune regulation. Endocrine Reviews, 29(5), 581–602.
  2. Catania, A., et al. (2010). The melanocortin system in immune modulation and inflammation control. Pharmacological Reviews, 62(2), 245–274.
  3. Luger, T. A., et al. (2003). Alpha-MSH and related peptides: Anti-inflammatory and immunomodulatory actions. Annals of the New York Academy of Sciences, 994, 133–140.
  4. Kannengiesser, K., et al. (2008). KPV inhibits NF-κB activation and reduces intestinal inflammation. Inflammatory Bowel Diseases, 14(3), 324–332.

Combined & Synergistic Benefits (Multi-Peptide Regenerative Effects)

  1. Pickart, L., & Sikiric, P. (2017). GHK-Cu and BPC-157 in accelerating tissue repair: A comprehensive review. Regenerative Medicine Journal, 12(4), 321–338.
  2. Sikiric, P., et al. (2018). Stable peptides in integrated tissue protection and regeneration: Angiogenesis, inflammation control, and cellular migration. Regenerative Medicine, 13(4), 321–336.
  3. Malinda, K. M., et al. (1999). Coordinated angiogenic and reparative signaling in peptide-mediated tissue regeneration. Journal of Investigative Dermatology, 113(3), 364–368.
  4. Catania, A., & Lipton, J. M. (2003). Melanocortin peptides and tissue protection: Anti-inflammatory and reparative mechanisms. Peptides, 24(3), 441–450.

**Note:** This product is intended for research purposes only and not for human consumption. Always consult with a healthcare professional before starting any new supplement or research product.

Researched Pairings

GHK-Cu

SKIN RENEWAL

A small clear glass vial with a gold cap labeled “GHK-Cu 50mg” and displaying a green stylized logo on a white background. The vial is used for holding a chemical or medical substance.

$95.00

View
Buy This product has multiple variants. The options may be chosen on the product page

Healing & Recovery Peptide Stack

Four clear glass vials with gold caps, labeled as Healing & Recovery Peptide Stack: C1295 + Ipam, BPC-157, TB-500, and GHK-Cu, each featuring dosage info on the label.

$450.00

View
Buy

Longevity & Anti-Aging Peptide Stack

Five clear vials with gold caps, labeled as the Longevity & Anti-Aging Peptide Stack, display dosage information on white labels.

$2,600.00

View
Buy

TB-500 (Thymosin Beta-4)

HEALING & REPAIR

A small glass vial with a gold cap, labeled “TB-500 (Thymosin Beta-4) 10 mg/2 ml” in green text, features a stylized green symbol above the label, and is isolated on a white background.

$165.00

View
Buy This product has multiple variants. The options may be chosen on the product page